SEC Form 4 · accession 0001209191-17-055345
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald A Rittenmeyer
Officer — Executive Chairman · Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070318
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 September Performance Stock Options (Right to Buy)F1 | $16.43 | Sep 29, 2017 | A | 408,526 | A | — | Sep 29, 2022 | Common Stock | 408,526 | 408,526 | D |
Explanation of responses
- F1These performance-based stock options vest on the first anniversary of the date of grant, and become exercisable only if the average closing price per share of the Company's common stock, calculated over any period of 30 sequential trading days during the four-year period following the date of grant, equals or exceeds $20.53.